is a topic covered in the Davis's Drug Guide
To view the entire topic, please sign in or purchase a subscription.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:
-- The first section of this topic is shown below --
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Quiring, Courtney, et al. "Reslizumab." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110405/all/reslizumab.
Quiring C, Sanoski CA, Vallerand AH. Reslizumab. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110405/all/reslizumab. Accessed April 20, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Reslizumab. In Davis's Drug Guide. Available from https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110405/all/reslizumab
Quiring C, Sanoski CA, Vallerand AH. Reslizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 April 20]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110405/all/reslizumab.
TY - ELEC
T1 - reslizumab
ID - 110405
A1 - Quiring,Courtney,
AU - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110405/all/reslizumab
PB - F.A. Davis Company
ET - 16
DB - Anesthesia Central
DP - Unbound Medicine